Bixiye
QP70-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2023
Taariikhda barnaamijka Dhaqangalayso Agosto 09, 2023
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1641 - 1650 ee natiijooyinka 3167
Bixiye
QP67-23 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda barnaamijka Dhaqangalayso Agosto 09, 2023
Bixiye
QP68-23 MHCP Pharmacy Benefit Exclusion for Columvi™, Elevidys, Rystiggo®, and Vyvgart® Hytrulo
Taariikhda barnaamijka Dhaqangalayso Agosto 09, 2023
Bixiye
QP66-23 Commercial Pharmacy Benefit Exclusion for Elevidys, Rystiggo®, and Vyvgart® Hytrulo
Taariikhda barnaamijka Dhaqangalayso Agosto 09, 2023
Bixiye
P27R1-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective July 6, 2020
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023
Bixiye
P56-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023
Bixiye
P57-23 Updated Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023
Bixiye
P58-23 Medicare Advantage Part B Step Therapy Program Expansion to Include Vyvgart and Ultomiris
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023
Bixiye
P53-23 Reimbursement Changes for Dental Providers, Effective October 1, 2023
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023
Bixiye
P54-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023